Skip to main content
Log in

Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Interleukin-10 (IL-10) is a major immunoregulatory cytokine and has a multitude of immunomodulatory effects in the immune system. In this study, we have examined the secretion andin vitro function of IL-10 in B cell hyperactivity in antibody production in two common autoimmune diseases, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). IL-10 was detectable in serum of all active SLE and serum and synovial fluid samples of all RA patients but in none of the normal controls. B cells and CD4+CD45RO+ “memory” T cells secreted highly enhanced levels of IL-10 in SLE and RA versus normals. Increased IgM and IgG production by B cells-CD4+CD45RO+ T cells in SLE and RA was IL-10 dependent, since neutralization of IL-10 cytokine by anti-IL-10 antibody drastically reduced Ig synthesis in these coculture experiments. B cell hyperactivity in autoantibody production in SLE and RA may be a function of IL-10-dependent CD4+CD45RO+ Th2 cell activation. Therefore, IL-10 may play an important role in highly disturbed immune system and B cell-T cell function in these immune disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse helper T cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2089, 1989

    PubMed  Google Scholar 

  2. O'Gara A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H, Barbis D, Stall A, Cupp J, Moore K, Vieira P, Mosmann T, Whitmore A, Arnold L, Haugton G, Howard M: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2:821–832, 1990

    PubMed  Google Scholar 

  3. de Waal MR, Abrams J, Bennett B, Figdor C, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes. An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220, 1991

    PubMed  Google Scholar 

  4. Fiorentino DF, Zlotnik A, Mossmann TR, Howard M, O'Gara A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822, 1991

    PubMed  Google Scholar 

  5. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick D: Interleukin-10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507–510, 1991

    PubMed  Google Scholar 

  6. Zlotnik A, Moore KW: Interleukin-10. Cytokines 3:366–371, 1991

    Google Scholar 

  7. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ. IL-10 mediates susceptibility to trypanosoma cruzi infection. J Immunol 153:3135–3140, 1994

    PubMed  Google Scholar 

  8. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell derived cytokine. Annu Rev Immunol 10:385–399, 1992

    PubMed  Google Scholar 

  9. Howard M, O'Garra A, Ishida H, de Waal MR, de Vries J: Biological properties of interleukin-10. J Clin Immunol 12:239–247, 1992

    PubMed  Google Scholar 

  10. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165–190, 1993

    PubMed  Google Scholar 

  11. Hahn BH: An overview of the etiology and pathogenesis of systemic lupus erythematosus.In Systemic Lupus Erythematosus, 4th ed, Wallace, Hahn (eds). Philadelphia, Lea & Fibger, 1992, pp 65–70

    Google Scholar 

  12. Paget SA, Gibofsky A: Immunopathogenesis of rheumatoid arthritis. Am J Med 67:961–970, 1979

    PubMed  Google Scholar 

  13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systmic lupus erythematosus. Arth Rheum 25:1271–1277, 1982

    Google Scholar 

  14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315–324, 1988

    Google Scholar 

  15. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S: Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis. J Rheumatol 20:1647–1653, 1993

    PubMed  Google Scholar 

  16. Al-Janadi M, Raziuddin S: B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885–1891, 1993

    PubMed  Google Scholar 

  17. Klinman DM: B cells.In Steinberg AD, moderator. Systemic lupus erythematosus. Ann Intern Med 115:550–555, 1991

    Google Scholar 

  18. Ueda Y, Sakane T, Tsunematsu T: Hyperactivity of activated B cells to B cell growth factor in patints with systemic lupus erythematosus. J Immunol 143:3988–3993, 1989

    PubMed  Google Scholar 

  19. Raziuddin S, Al-Janadi M, Al-Wabel AA: Soluble interleukin-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestation of the disease in patients with systemic lupus erythematosus. J Rheumatol 18:831–836, 1991

    PubMed  Google Scholar 

  20. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR: Elevated levels of endogeneous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123, 1991

    PubMed  Google Scholar 

  21. Hochberg MC: Systemic lupus erythematosus. Rheum Dis Clin North Am 16:613–639, 1990

    Google Scholar 

  22. Raziuddin S, Nur MA, Al-Wabel AA: Selective loss of the CD4+ inducers of T cell subsets (2H4) in active systemic lupus erythematosus. J Rheumatol 16:1315–1319, 1989

    PubMed  Google Scholar 

  23. Morimoto C, Romain PL, Fox DA, Schlossman SF: Abnormalities in CD4+ T lymphocyte subsets in inflammatory rheumatic diseases. Am J Med 84:817–825, 1988

    PubMed  Google Scholar 

  24. Emery P, Gentry KC, Makay IR, Muirden KD, Rowley M: Deficiency of the suppressor-inducer subsets of T lymphocytes in rheumatoid arthritis. Arth Rheum 30:849–856, 1987

    Google Scholar 

  25. Morimoto C, Steinberg AD, Letvin NL, Fox DA, Romain PL, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated by anti-2H4 antibody. J Clin Invest 79:762–768, 1987

    PubMed  Google Scholar 

  26. Horwitz DA, Wang HA, Gray JD: Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: Increased interleukin-2 but not interleukin-4 mRNA. Lupus 3:423–428, 1994

    PubMed  Google Scholar 

  27. Zagon G, Tumang JR, Li Y, Friedman ST, Crow MK: Increased frequency of Vb17-positive T cells in patients with rheumatoid arthritis. Arth Rheum 37:1431–1440, 1994

    Google Scholar 

  28. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Smolen J, Graninger WB. High levels of bcl-2 protein in circulating lymphocytes but not B lymphocytes of patients with systemic lupus erythematosus. Arth Rheum 37:1423–1430, 1994

    Google Scholar 

  29. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC: serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 82:2169–2174, 1993

    PubMed  Google Scholar 

  30. Smilie D, Touitou R, Raphel M, Peuchmaur M, Devergnee O, Rea D, Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937–2942

  31. Baiocchi R, Ross ME, Tan JC, Chou CC, Sulivan L, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundent production of human interleukin-10. Blood 85:1063–1074, 1995

    PubMed  Google Scholar 

  32. Katsikis PD, Chu CQ, Brenan FM, Mainin RN, Feldmann M. Immunoregulatory role in interleukin-10 in RA. J Exp Med 179:1517–1521, 1994

    PubMed  Google Scholar 

  33. Taga K, Chernay B, Tosato G: IL-10 inhibits apoptic cell death in humans T cells starved of IL-2. Int Immunol 5:1599–1604, 1993

    PubMed  Google Scholar 

  34. Cohen SB, Katsikis PD, Feldmann M, Londei M: IL-10 enhance expression of the IL-2 receptorα chain on T cells. Immunology 83:329–332, 1994

    PubMed  Google Scholar 

  35. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:4167–4172, 1990

    PubMed  Google Scholar 

  36. Via CS, Handwerger BS: T cell and B cell function in lupus. Curr Opinion Rhumatol 4:630–634, 1992

    Google Scholar 

  37. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptic death of Ly 1 (CD5+) B cells responsible for autoimmune disease in transgenic mice. Nature 357:77–80, 1992

    PubMed  Google Scholar 

  38. O'Gara A, Chang R, Hastings R, Go N, Haughton G, Howard M: Ly1B (B1) cells are the main source of B cell derived IL-10. Eur J Immunol 22:711–717, 1992

    PubMed  Google Scholar 

  39. Ishida H, Hastings R, Kearney J, Howard M: Continuous anti-IL-1 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175:1213–1220, 1992

    PubMed  Google Scholar 

  40. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305–310, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Janadi, M., Al-Dalaan, A., Al-Balla, S. et al. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol 16, 198–207 (1996). https://doi.org/10.1007/BF01541225

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01541225

Key words

Navigation